Table 1.

Summary of cases with early postoperative COVID‐19

Case	Age, sex, and BMI	Liver Disease	Comorbidities	Donor data	Surgical data	Immunosuppression protocol	COVID‐19 symptoms	COVID‐19 treatment and outcome
1	69 y, female BMI: 34.71 kg/m2	HCV Downstaged HCC MELD: 15 Child‐Pugh: A6	SAH Coronariopathy Pulmonary hypertension	Female, 45 y BD: hemorrhagic stroke	GW: 1600 g TST: 285 min TIT: 585 min WIT: 35 min BBP: None	Basiliximab, tacrolimus, mycophenolate and intraoperative corticoid bolus and tampering	9th POD Fever Mild dyspnea Diarrhea	OTI on 12th POD Azithromycin Death on 13th POD due to due to refractory shock and acidosis.
2	67 y, male BMI: 32.81 kg/m2	NASH α1‐antitripsin deficiency MELD: 13 Child‐Pugh: B7 Hepatic encephalopathy	SHA Obesity	Female, 22 y BD: subarachnoid hemorrhage 21 d ICU AST 156 UI/mL ALT 296 UI/mL GGT 584 mg/dL	GW: 1475 g TST: 435 min TIT: 445 min WIT: 40 min BBP: None	Basiliximab, tacrolimus, mycophenolate and intraoperative corticoid bolus and tampering	36th POD Fever Hypoactive Delirium Progressive dyspnea	OTI on 37th POD Azithromycin Hydroxychloroquine Death on 56th POD due to secondary bacterial infection
3	69 y, male BMI: 27.58 kg/m2	Alcoholic cirrhosis HCC MELD: 13 Child‐Pugh: A6	SHA DM	Male, 54 y BD: cranioencephalic trauma	GW: 1370 g TST: 425 min TIT: 405 min WIT: 35 min BBP: None	Tacrolimus and intraoperative corticoids bolus with tampering	10th POD Fever watery diarrhea dry cough Mild exertional dyspnea	Venturi mask Supportive care Dyspnea worsened on 10th hospitalization day Discharged home on 17th hospitalization day
4	59 y, male BMI: 24.38 kg/m2	Cryptogenic cirrhosis Ascites Hepatic encephalopathy MELD: 10 Child‐Pugh: B7	Hepatosplenic schistosomiasis	Female, 52 y BD: hemorrhagic stroke Presented cardiac arrest before organ recovery	GW: 1450 g TST: 360 min TIT: 460 min WIT: 35 min BBP: None	Tacrolimus, mycophenolate and intraoperative corticoid bolus and tampering. Received PMT for acute cellular rejection treatment	11st POD Subfebrile temperature dry cough	Supportive care Discharged on 27th POD
5	34 y, male BMI: 22.38 kg/m2	Sclerosing primary cholangitis MELD: 35 Child B7	None	Female, 42 y BD: ischemic stroke	GW: 1425 g TST: 395 min TIT: 360 min WIT: 35 min BBP: None	Tacrolimus and intraoperative corticoids bolus with tampering. Mycophenolate, PMT, anti‐thymocyte globulin were later used due to steroid‐resistant severe acute cellular rejection	18th POD: asymptomatic 24th POD: Fever Mild dyspnea	Supportive care Needle thoracocentesis drainage of pleural effusion Discharged home on 41st POD

Abbreviations: ALT, alanine aminotransferase; AST, aspartate aminotransferase; BBP, blood‐borne products; BD, brain death; BMI, body mass index; DM, diabetes mellitus; GGT, gamma‐glutamyl transferase; GW, graft weight; HCC, hepatocellular carcinoma; HCV, hepatitis C virus; ICU, intensive care unit; MELD, model of end‐stage liver disease; NASH, non‐alcoholic steatohepatitis; PMT, pulse methylprednisolone therapy POD, postoperative day; SHA, systemic artery hypertension; TIT, total ischemic time; TST, total surgery time; WIT, warm ischemic time.